Paloma Partners Management CO Alaunos Therapeutics, Inc. Transaction History

Paloma Partners Management CO

  • $3.28 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$2.09 - $3.09 $36,464 - $53,911
-17,447 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$2.39 - $3.43 $41,698 - $59,843
17,447 New
17,447 $44,000
Q4 2019

Feb 14, 2020
SELL
$3.95 - $5.35 $167,875 - $227,374
-42,500 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$4.13 - $6.94 $175,525 - $294,950
42,500 New
42,500 $182,000

Others Institutions Holding TCRT

# of Institutions
5
Shares Held
92.6K
Call Options Held
0
Put Options Held
0
View Full List

About Alaunos Therapeutics, Inc.

TCRT Quotes by TradingView
  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $443M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email